These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 27701127)
1. Efficacy and Safety of a Novel Autologous Wound Matrix in the Management of Complicated, Chronic Wounds: A Pilot Study. Kushnir I; Kushnir A; Serena TE; Garfinkel D Wounds; 2016 Sep; 28(9):317-327. PubMed ID: 27701127 [TBL] [Abstract][Full Text] [Related]
2. Safety and Efficacy of an Autologous Blood Clot Product in the Management of Texas 1A or 2A Neuropathic Diabetic Foot Ulcers: A Prospective, Multicenter, Open Label Pilot Study. Snyder RJ; Kasper MA; Patel K; Carter MJ; Kushnir I; Kushnir A; Serena TE Wounds; 2018 Jul; 30(7):84-89. PubMed ID: 29718812 [TBL] [Abstract][Full Text] [Related]
3. Use of autologous whole blood clot in the treatment of complex surgical wounds: a case series. Gurevich M; Heinz SM; Fridman R; Hawkins J; Wachuku CD J Wound Care; 2023 Feb; 32(Sup2):S4-S9. PubMed ID: 36744737 [TBL] [Abstract][Full Text] [Related]
4. The clinical relevance of treating chronic wounds with an enhanced near-physiological concentration of platelet-rich plasma gel. de Leon JM; Driver VR; Fylling CP; Carter MJ; Anderson C; Wilson J; Dougherty RM; Fuston D; Trigilia D; Valenski V; Rappl LM Adv Skin Wound Care; 2011 Aug; 24(8):357-68. PubMed ID: 21768787 [TBL] [Abstract][Full Text] [Related]
5. A pilot study to evaluate the safety and clinical performance of Leucopatch, an autologous, additive-free, platelet-rich fibrin for the treatment of recalcitrant chronic wounds. Jørgensen B; Karlsmark T; Vogensen H; Haase L; Lundquist R Int J Low Extrem Wounds; 2011 Dec; 10(4):218-23. PubMed ID: 22009148 [TBL] [Abstract][Full Text] [Related]
6. Chronic wounds treated with a physiologically relevant concentration of platelet-rich plasma gel: a prospective case series. Frykberg RG; Driver VR; Carman D; Lucero B; Borris-Hale C; Fylling CP; Rappl LM; Clausen PA Ostomy Wound Manage; 2010 Jun; 56(6):36-44. PubMed ID: 20567053 [TBL] [Abstract][Full Text] [Related]
7. Clinical experience using a dehydrated amnion/chorion membrane construct for the management of wounds. Caporusso J; Abdo R; Karr J; Smith M; Anaim A Wounds; 2019 Apr; 31(4 Suppl):S19-S27. PubMed ID: 30933904 [TBL] [Abstract][Full Text] [Related]
8. Utilization of a Viable Human Amnion Membrane Allograft in Elderly Patients With Chronic Lower Extremity Wounds of Various Etiologies. Regulski M Wounds; 2018 Mar; 30(3):E36-E40. PubMed ID: 29584608 [TBL] [Abstract][Full Text] [Related]
9. Randomized clinical trial of autologous skin cell suspension combined with skin grafting for chronic wounds. Hu ZC; Chen D; Guo D; Liang YY; Zhang J; Zhu JY; Tang B Br J Surg; 2015 Jan; 102(2):e117-23. PubMed ID: 25627123 [TBL] [Abstract][Full Text] [Related]
10. Clinical Assessment of a Biofilm-disrupting Agent for the Management of Chronic Wounds Compared With Standard of Care: A Therapeutic Approach. Kim D; Namen Ii W; Moore J; Buchanan M; Hayes V; Myntti MF; Hakaim A Wounds; 2018 May; 30(5):120-130. PubMed ID: 29521641 [TBL] [Abstract][Full Text] [Related]
11. A prospective pilot study to evaluate wound outcomes and levels of serum C-reactive protein and interleukin-6 in the wound fluid of patients with trauma-related chronic wounds. Liu T; Yang F; Li Z; Yi C; Bai X Ostomy Wound Manage; 2014 Jun; 60(6):30-7. PubMed ID: 24905355 [TBL] [Abstract][Full Text] [Related]
12. Effectiveness of an extracellular matrix graft (OASIS Wound Matrix) in the treatment of chronic leg ulcers: a randomized clinical trial. Mostow EN; Haraway GD; Dalsing M; Hodde JP; King D; J Vasc Surg; 2005 May; 41(5):837-43. PubMed ID: 15886669 [TBL] [Abstract][Full Text] [Related]
13. State-of-the-art wound healing: skin substitutes for chronic wounds. Han G Cutis; 2014 Jan; 93(1):E13-6. PubMed ID: 24505591 [TBL] [Abstract][Full Text] [Related]
14. Allogeneic Platelet-Rich Plasma Therapy as an Effective and Safe Adjuvant Method for Chronic Wounds. Liao X; Liang JX; Li SH; Huang S; Yan JX; Xiao LL; Song JX; Liu HW J Surg Res; 2020 Feb; 246():284-291. PubMed ID: 31622885 [TBL] [Abstract][Full Text] [Related]
15. Autologous platelet-rich plasma for treating chronic wounds. Brick N Am J Nurs; 2013 Aug; 113(8):54. PubMed ID: 23884000 [No Abstract] [Full Text] [Related]
16. Efficacy of a Bioresorbable Matrix in Healing Complex Chronic Wounds: An Open-Label Prospective Pilot Study. Manning SW; Humphrey DA; Shillinglaw WR; Crawford E; Pranami G; Agarwal A; Schurr MJ Wounds; 2020 Nov; 32(11):309-318. PubMed ID: 33465043 [TBL] [Abstract][Full Text] [Related]
17. The Use of Active Coagulation Whole Blood-An Innovative Treatment Strategy for Hard-To-Heal Wounds. Haim N; Kaufman JP; Gurevich M Am Surg; 2024 Apr; 90(4):710-716. PubMed ID: 37878333 [TBL] [Abstract][Full Text] [Related]
18. Platelet-rich plasma and chronic wounds: remaining fibronectin may influence matrix remodeling and regeneration success. Moroz A; Deffune E Cytotherapy; 2013 Nov; 15(11):1436-9. PubMed ID: 23993645 [TBL] [Abstract][Full Text] [Related]
19. Non-interventional study to investigate the efficacy and safety of Tegaderm™ Matrix in the treatment of patients with therapy-refractory chronic wounds. Weindorf M; Körber A; Klode J; Dissemond J J Dtsch Dermatol Ges; 2012 Jun; 10(6):412-20. PubMed ID: 21999577 [TBL] [Abstract][Full Text] [Related]
20. Effect of autologous epidermal cell suspension transplantation in chronic nonhealing wounds: a pilot study. Shukla VK; Tiwary SK; Barnwal S; Gulati AK; Pandey SS Can J Surg; 2010 Feb; 53(1):6-10. PubMed ID: 20100406 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]